市場調査レポート
商品コード
1078037
婦人科系疾患治療薬の世界市場(2022年~2028年)Global Women Health Therapeutics Market 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
婦人科系疾患治療薬の世界市場(2022年~2028年) |
出版日: 2022年04月13日
発行: Orion Market Research
ページ情報: 英文 135 Pages
納期: 2~3営業日
|
世界の婦人科系疾患治療薬の市場規模は、予測期間中にCAGRで5.3%の大幅な成長が予測されています。市場の成長に寄与している主な要因の1つは、乳がんの負担の増大による、健康診断と治療薬に対する世界的な需要の高まりです。
当レポートでは、世界の婦人科系疾患治療薬市場について調査分析し、市場概要、競合情勢、セグメント分析、地域分析などを提供しています。
Global Women Health Therapeutics Market Size, Share & Trends Analysis Report by Type (Infection, Pregnancy, and Oncology), and by End-User (Hospitals and Clinics and Ambulatory Centers) Forecast Period (2022-2028)
The global women health therapeutics market is anticipated to grow at a considerable CAGR of 5.3% during the forecast period. One of the core factors contributing to the growth of the market includes the growing demand forhealth diagnostics and therapeutics across the globe.This is due to the growing burden of breast cancer. Breast cancer is the most common cancer in women in the US. About 30% (or 1 in 3) of all new femalesare diagnosed with cancers each year. According to the American Cancer Society of the US, in 2022, about 287,850 new cases of invasive breast cancer were diagnosed in women. Furthermore, the rising several R&D and drug approval activities by key market players globally is another factor bolstering the market growth. For instance, inOctober 2021, the FDA approved a new drug for one type of breast cancer. The drug, named abemaciclib underthe brand name Verzenio, was approved for patients with the HR+, HER2-early breast cancer, which makes up 70% of all breast cancers.
The global women health therapeuticsmarket is segmented based on the type and end-user. Based on type, the market is classified into infection, pregnancy, and oncology. The oncology segment is further augmented into cervical cancer, uterine cancer, ovarian cancer, and vaginal &vular. Based on the end-user, the market is segmented into hospitals and clinics, and ambulatory centers. The above-mentioned segments can be customized as per the requirements.
Geographically the global women health therapeuticsmarket is segmented into North America, Europe, Asia Pacific, and the Rest of the World.North America is expected to hold a significant share in the global market due to the growing focus onwomen health and the increasing prevalence of chronic disorders such as breast and ovarian cancer.According to Globocan, in 2020, around 2.26 million new breast cancer cases were reported in females, accounting for around 11.7% of the total cancer cases. Severalproduct launches areanother key factor to drive the growth of the market across the region. For instance, in January 2021, Roche launched its CE-IVD-approved automated digital pathology algorithms, uPath HER2 (4B5) imageanalysis, and uPath HER2 Dual ISH image analysis for breast cancer.
The major companies serving the global women health therapeutics market include Novartis AG, Abbott Laboratories, Inc., Pfizer Inc., Eli Lilly and Co., Bayer AG, Merck KGaA, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers andacquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2021, Abbott acquired Walk Vascular LLC, a commercial-stage medical device firm with a minimally hostile mechanical aspiration thrombectomy system for the elimination of peripheral blood clots.
Research Methodology
The market study of the global women health therapeutics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers
Category- Pharmaceuticals